ImmunoScape vs Pyxis Diagnostics

ImmunoScape vs Pyxis Diagnostics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: ImmunoScape is on 58/100 and Pyxis Diagnostics on 51/100.

ImmunoScape logo
ImmunoScapeDeveloping novel immunotherapies and diagnostics for cancer.
Try ImmunoScape
Pyxis Diagnostics logo
Pyxis DiagnosticsDeveloping novel diagnostics to predict patient response to immunotherapy.
Try Pyxis Diagnostics

Where each one leads

ImmunoScape

  • our overall score: 58/100 against 51/100
  • agent readiness: 39/100 against 22/100
  • domain rating: 28/100 against 3/100
  • funding raised: $49.7M against $10.0M
  • LinkedIn following: 4,364 against 398

Pyxis Diagnostics

Leads on none of the measures we hold for both companies.

At a glance

MeasureImmunoScapePyxis Diagnostics
What it isDeveloping novel immunotherapies and diagnostics for cancer.Developing novel diagnostics to predict patient response to immunotherapy.
CategoryBiotechnology, Cancer, Immunotherapy, DiagnosticsHealthcare, Immunotherapy, Oncology, Next Generation Sequencing
Sells toBusiness modelB2BB2B
OfferingPlatformSoftware
Founded20172017
HeadquartersSingapore, SingaporeSan Diego, United States
StatusActiveInactive

Size, funding and growth

MeasureImmunoScapePyxis Diagnostics
EmployeesNot published3
Headcount growthLast 12 monthsNot published-39.5%
Total funding$49.7M$10.0M
Latest roundSeries B2Seed
Valuation$1.1BNot published
LinkedIn followers4,364398

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureImmunoScapePyxis Diagnostics
StartupHub scoreOur 0-100 rating58/10051/100
Traction38/10041/100
Team70/10070/100
CommunityNot published15/100
Search visibility23/10026/100
Quality68/10058/100
Agent readinessHow well an AI agent can read and act on the siteF (39/100)F (22/100)
Domain ratingLink authority, 0-10028/1003/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureImmunoScapePyxis Diagnostics
CDNCloudflareNot detected
CMSWordPressWix
FrameworksJqueryJquery
AnalyticsGoogle Tag ManagerNot detected

What users say

MeasureImmunoScapePyxis Diagnostics
Reddit sentimentThreads we track6 positive, 0 negative across 6 threadsNot published
ImmunoScape
Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments.
r/Quantisnow

ImmunoScape vs Pyxis Diagnostics: common questions

Which is better, ImmunoScape or Pyxis Diagnostics?

On our 0-100 score ImmunoScape rates higher (58/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.

How do ImmunoScape and Pyxis Diagnostics compare on the numbers?

ImmunoScape leads on our overall score (58/100 against 51/100), agent readiness (39/100 against 22/100), domain rating (28/100 against 3/100), funding raised ($49.7M against $10.0M), LinkedIn following (4,364 against 398).

What do real users say about ImmunoScape and Pyxis Diagnostics?

ImmunoScape: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/Quantisnow.

Read the full ImmunoScape review and pricing or the Pyxis Diagnostics review and pricing. You can also browse other ImmunoScape alternatives we track.